90 likes | 118 Views
The “global drug-eluting stents market” is estimated to witness a CAGR of 5.4% during the forecast period 2018–2024. https://bit.ly/2NZYWJl For free sample: https://bit.ly/2OJek1Y
E N D
Description Drug-eluting stents refer to the metal stents that have a coating of drugs such as paclitaxel, everolimus, and also antiproliferative drugs to widen the narrowed blood vessel. The first-generation DES has raised safety issues due to a higher incidence of stent thrombosis, which has further given rise to biodegradable DES to provide better treatment. The ability to release an antiproliferative drug that avoids neointimal proliferation, which reduces the incidence of stent restenosis and prevent the need of restenting. These benefits contributed to the domination of DES in 2016. However, thrombosis, along with vasomotion, is the major issue that needs to be addressed in the DES market. Drug-eluting stents find importance in cardiovascular complications as it is a minimally invasive surgical procedure, broadens the constricted blood vessels, and is useful in prolonging the life of the patient.Report Link: https://www.infoholicresearch.com/report/drug-eluting-stents-market-2024/
Market Growth The “global drug-eluting stents market” is estimated to witness a CAGR of 5.4% during the forecast period 2018–2024.
Key Players Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Terumo Corporation, Biosensors International Group, Meril Life Science, Stentys SA, Cook Medical Inc., and Lepu Medical Technology. Currently, many manufacturers are outsourcing research to clinical research organizations, which is indirectly boosting the growth of the drug-eluting stents market.
Table of content 1 Industry Outlook 2 Report Outline 3 Market Snapshot 4 Market Outlook 5 Market Characteristics 6 By Type: Market Size and Analysis 7 Technology: Market Size and Analysis 8 Regions: Market Size and Analysis 9 End-Users: Market Size and Analysis 10 Competitive Landscape 11 Vendors profile 12 Annexure
Methodology • Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps: • Data Collation (Primary & Secondary) • In-house Estimation (Based on proprietary data bases and Models) • Market Triangulation • Forecasting
About us Infoholic Research (https://www.infoholicresearch.com/)is a global market research and consulting organization providing strategic and high-level market intelligence in emerging and niche markets in Healthcare, ICT, Semiconductors, Chemicals & Materials domain. We aim at delivering high-quality results to our clients providing them with in-depth industry insights to identify new business opportunities and nurture their business strategies. Our team of analysts spanning verticals such as ICT, Healthcare, Chemicals and Semiconductors creates extensive Market Research reports every month covering market trends and dynamics envisioning the road ahead. You may also send in your requests for getting our analysts’ viewpoints in specific areas of Healthcare, ICT, Chemicals & Materials, and Semiconductors to validate a certain market trend/ insight or finding. Please let me know how we both can create a cohesive quotient and associate for creating a win-win situation for both of us.
Contact Us Infoholic Research45/1, Residency Road Cross,5th Floor, Leo Shopping Complex, Bengaluru – 560025, IndiaEmail: sales@infoholicresearch.com https://www.linkedin.com/company/infoholic-research/